325 related articles for article (PubMed ID: 11708830)
21. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.
Reiner NE; Finke JH
J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858
[TBL] [Abstract][Full Text] [Related]
22. Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis.
de Melo CVB; Hermida MD; Mesquita BR; Fontes JLM; Koning JJ; Solcà MDS; Benevides BB; Mota GBS; Freitas LAR; Mebius RE; Dos-Santos WLC
Front Immunol; 2020; 11():653. PubMed ID: 32351510
[No Abstract] [Full Text] [Related]
23. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
Bhowmick S; Ravindran R; Ali N
Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
[TBL] [Abstract][Full Text] [Related]
24. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens.
Afrin F; Ali N
J Parasitol; 1998 Aug; 84(4):743-8. PubMed ID: 9714204
[TBL] [Abstract][Full Text] [Related]
25. KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.
Bhaumik S; Basu R; Sen S; Naskar K; Roy S
Vaccine; 2009 Feb; 27(9):1306-16. PubMed ID: 19162111
[TBL] [Abstract][Full Text] [Related]
26. Mast cells at the host-pathogen interface: host-protection versus immune evasion in leishmaniasis.
Saha B; Tonkal AM; Croft S; Roy S
Clin Exp Immunol; 2004 Jul; 137(1):19-23. PubMed ID: 15196239
[TBL] [Abstract][Full Text] [Related]
27. Importance of lymphokines in the control of multiplication and dispersion of Leishmania donovani within liver macrophages of resistant and susceptible mice.
Olivier M; Proulx C; Tanner CE
J Parasitol; 1989 Oct; 75(5):720-7. PubMed ID: 2529362
[TBL] [Abstract][Full Text] [Related]
28. IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology.
Satoskar AR; Rodig S; Telford SR; Satoskar AA; Ghosh SK; von Lichtenberg F; David JR
Eur J Immunol; 2000 Mar; 30(3):834-9. PubMed ID: 10741399
[TBL] [Abstract][Full Text] [Related]
29. Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response.
Rosa R; Rodrigues OR; Marques C; Santos-Gomes GM
Exp Parasitol; 2005 Feb; 109(2):106-14. PubMed ID: 15687017
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
Murray HW; Masur H; Keithly JS
J Immunol; 1982 Jul; 129(1):344-50. PubMed ID: 7086136
[No Abstract] [Full Text] [Related]
31. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
Bhattacharjee S; Bhattacharjee A; Majumder S; Majumdar SB; Majumdar S
J Antimicrob Chemother; 2012 Aug; 67(8):1905-14. PubMed ID: 22589456
[TBL] [Abstract][Full Text] [Related]
32. Destruction of follicular dendritic cells during chronic visceral leishmaniasis.
Smelt SC; Engwerda CR; McCrossen M; Kaye PM
J Immunol; 1997 Apr; 158(8):3813-21. PubMed ID: 9103448
[TBL] [Abstract][Full Text] [Related]
33. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
34. Leishmania infantum: mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice.
Rolão N; Cortes S; Gomes-Pereira S; Campino L
Exp Parasitol; 2007 Mar; 115(3):270-6. PubMed ID: 17087930
[TBL] [Abstract][Full Text] [Related]
35. rIL-2-stimulated splenocytes reactivate the NO2-producing ability of macrophages infected by Leishmania donovani.
Eslami Z; Tanner CE
Immunopharmacol Immunotoxicol; 2000 Aug; 22(3):465-87. PubMed ID: 10946826
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis.
Bhardwaj S; Vasishta RK; Arora SK
Exp Parasitol; 2009 Jan; 121(1):29-37. PubMed ID: 18983842
[TBL] [Abstract][Full Text] [Related]
37. Histopathology of lymphoid organs in experimental leishmaniasis.
Corbett CE; Paes RA; Laurenti MD; Andrade Júnior HF; Duarte MI
Int J Exp Pathol; 1992 Aug; 73(4):417-33. PubMed ID: 1390190
[TBL] [Abstract][Full Text] [Related]
38. Splenic immune responses during canine visceral leishmaniasis.
Strauss-Ayali D; Baneth G; Jaffe CL
Vet Res; 2007; 38(4):547-64. PubMed ID: 17540157
[TBL] [Abstract][Full Text] [Related]
39. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
Manna PP; Chakrabarti G; Bandyopadhyay S
Vaccine; 2010 Jan; 28(3):803-10. PubMed ID: 19879234
[TBL] [Abstract][Full Text] [Related]
40. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
Engwerda CR; Smelt SC; Kaye PM
Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]